Research Article

Application of Arsenic Trioxide-Based Combined Sequential Chemotherapy in Recurrent Resistant and Refractory Ovarian Cancers: A Single-Center, Open Phase II Clinical Study

Table 4

Possible treatment-related adverse events in the safety population.

Adverse eventAny gradeGrades 3 to 4

Any adverse eventNo%No%
Marrow suppression33100%2473%
Anemia2885%412%
Neutropenia33100%2370%
Thrombocytopenia1236%13%
Drug-induced liver injury618%00
Pyrexia618%00
Diarrhea26%00
Nausea13%00
Vomiting13%00
Abdominal pain13%00
Constipation13%00
Abdominal distension13%00
Mucositis/stomatitis13%00
Abdominal pain, upper13%00
Peripheral neuropathy13%00
Rash13%00